Oncolytic Virus Immunotherapy Market Outlook: Transforming Cancer Treatment Through Targeted Viral Therapies
The Oncolytic Virus Immunotherapy Market is gaining strong traction as next-generation cancer therapies shift toward immune-based and precision treatment approaches. With a base year of 2024 and historical assessment from 2025–2035, the market demonstrates robust growth driven by rising cancer prevalence, increasing clinical success of oncolytic viruses, and expanding investments in immuno-oncology research. Market Overview and Growth … Read more